Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.


Inflammation of the liver, due usually to viral infection but sometimes to toxic agents.
[hepat- + -itis]

Previously endemic throughout much of the developing world, viral hepatitis now ranks as a major public health problem in industrialized nations. The three most common types of viral hepatitis (A, B, and C) afflict millions worldwide. Acute viral hepatitis is characterized by varying degrees of fever, malaise, weakness, anorexia, nausea, and abdominal distress. Hepatocellular damage causes bilirubin retention, often with jaundice, and a rise in serum levels of certain enzymes (particularly transaminases). Hepatitis A, caused by an RNA enterovirus, is spread by the fecal-oral route, most often through ingestion of contaminated food or water. The case fatality rate is less than 1% and recovery is complete. The presence of antibody to hepatitis A virus indicates prior infection or successful immunization, noninfectivity, and immunity to future attacks. Hepatitis B, due to a small DNA virus of the Hepadnaviridae family, is transmitted through sexual contact, sharing of needles by IV drug abusers, needlestick injuries among health care workers, and from mother to fetus. This disease is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The annual incidence of hepatitis B in the U.S. is 300,000 cases. The incubation period is 6-24 weeks. Some patients become carriers, and in some, an immune response to the virus induces a chronic phase leading to cirrhosis, hepatic failure, and risk of hepatocellular carcinoma. Hepatitis B surface antigen (HbsSAg) appears in the serum early in the disease; its persistence correlates with chronic infection and infectivity. Core antigen (HbcCAg) appears later and also indicates infectivity. The presence of antibodies to these antigens implies recovery and noninfectivity. Hepatitis C, caused by an RNA virus of the Flaviviridae family, was the principal form of transfusion-induced hepatitis before the early 1990s, when screening of donor blood for this virus was initiated. About two thirds of those currently infected have a history of IV drug abuse. The disease can also be transmitted by needles used for body piercing or tattooing and (less often) sexually or from mother to fetus. Early infection is usually asymptomatic. Antibodies to various components of the virus appear early but do not neutralize the virus. The disease is nonetheless self-limited in 15-20% of patients. The rest develop chronic infection, with persistence of detectable viral RNA, and about half experience slowly progressive deterioration of hepatic function. Cirrhosis occurs in 15-20% of patients with hepatitis C. Extrahepatic manifestations of hepatitis C virus infection include cryoglobulinemia, glomerulonephritis, and non-Hodgkin lymphoma. Acute infection with hepatitis B or C has a higher mortality rate than hepatitis A. Effective vaccines are available for active immunization against hepatitis A and hepatitis B. Interferon-alfa 2b and lamivudine are sometimes effective in hepatitis B. Combination therapy with interferon-alfa 2a, interferon-alfa 2b, and ribavirin brings about clinical remission in some cases of hepatitis C. Responsiveness depends in part on the genotype of the virus. Hepatitis D is due to a defective RNA virus capable of causing disease only in those previously infected by hepatitis B virus. People infected by both hepatitis B and hepatitis D viruses are at high risk of developing fulminant hepatitis and cirrhosis. Prolonged treatment with interferon is somewhat effective. Hepatitis E, which occurs chiefly in the tropics, resembles hepatitis A in that it is transmitted by the fecal-oral route and does not become chronic or lead to a carrier state, but it has a much higher mortality rate.

Farlex Partner Medical Dictionary © Farlex 2012


n. pl. hepa·titides (-tĭt′ĭ-dēz′)
1. Inflammation of the liver, caused by infectious or toxic agents and characterized by jaundice, fever, liver enlargement, and abdominal pain.
2. Any of various types of such inflammation, especially viral hepatitis.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.


A generic term for any type of liver inflammation.

• Viruses—HAV, HBV, hepatitis non-A, non-B (HCV, HDV, HEV, CMV), coxsackievirus, herpesvirus, EBV, measles, mumps, rubella, rubeola;
• Bacteria;
• Parasites;
• Fungi.
• Alcohol;
• Drugs;
• Chemicals and toxins;
• Hyperthermia;
• Radiation.

Clinical findings
Anorexia, nausea, vomiting, malaise, jaundice, myalgia, arthralgia, photophobia, bleeding, diathesis.
Increased transaminases (ALA, AST, GGT, BR), immunoglobulins; decreased vitamin K-dependent coagulation factors, ergo increased prothrombin time. Viral hepatitis is diagnosed by serology, measuring viral antigen(s) or antibodies formed against the antigens; non-viral hepatitides are diagnosed by history and exclusion of virus.
Acute hepatitis—no treatment (steroids, IFN-a are not recommended); chronic hepatitis—corticosteroids, IFN-a may prolong survival and improve outcomes.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.


Hepatology Liver inflammation Etiology-infectious HAV, HBV, hepatitis non-A, non-B–HCV, HDV, HEV, CMV, coxsackievirus, herpesvirus, EBV, measles, mumps, rubella, rubeola, bacteria, parasites, fungi Etiology-noninfectious Alcohol, drugs, chemicals and toxins, hyperthermia, radiation Clinical Anorexia, N&V, malaise, jaundice, myalgia, arthralgia, photophobia, bleeding diathesis Lab ↑ Transaminases–ALA, AST, GGT, BR, Igs, ↓ vitamin K-dependent coagulation factors, ergo ↑ prothrombin time; viral hepatitis is diagnosed by serology, measuring viral antigen(s) or antibodies formed against the antigens; non-viral hepatitides are diagnosed by history and exclusion of virus Management Acute hepatitis, no treatment–steroids, IFN-α are not recommended; chronic hepatitis–corticosteroids, IFN-α may prolong survival and improve outcomes. See Acute hepatitis, Biochemical hepatitis, Chronic hepatitis, Giant cell hepatitis, Halothane hepatitis, Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E, Hepatitis F, Hepatitis GB, Hepatitis non-A–G, Lupoid hepatitis, Neonatal hepatitis, Non-A, non-B hepatitis.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.


Inflammation of the liver; usually from a viral infection, a drug, or toxic agent.
[hepat- + -itis]
Medical Dictionary for the Health Professions and Nursing © Farlex 2012


a serious disorder of the liver that leads to severe jaundice, liver degeneration and even death. The condition is caused by two viruses: hepatitis A virus, which produces infective hepatitis transmitted by the intestinal-oral route, and hepatitis B virus, which produces serum hepatitis transmitted via infected blood or its products. Although these two viral types can be distinguished in tests, the acute diseases caused by each may be clinically indistinguishable, the chief difference being that type A usually has a shorter incubation period than type B. No specific therapy is available for hepatitis, although vaccines are being developed.
Collins Dictionary of Biology, 3rd ed. © W. G. Hale, V. A. Saunders, J. P. Margham 2005


An inflammation of the liver, with accompanying liver cell damage or cell death, caused most frequently by viral infection, but also by certain drugs, chemicals, or poisons. May be either acute (of limited duration) or chronic (continuing). Symptoms include jaundice, nausea, vomiting, loss of appetite, tenderness in the right upper abdomen, aching muscles, and joint pain. In severe cases, liver failure may result.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.


Inflammation of the liver, due usually to viral infection but sometimes to toxic agents.
[hepat- + -itis]

hep·a·ti·tis, vi·ral, non-A, non-B

(NANB) (hepă-tītis, vīrăl)
Disease due to viral agents other than hepatitis viruses A or B.
Medical Dictionary for the Dental Professions © Farlex 2012

Patient discussion about Hepatitis

Q. Do I have hepatitis? I'm volunteering in a shelter for homeless people, and there are many drug addicts there. Yesterday, as I was serving them food one of the residents of the shelter (who I know to be a long term drug addict that uses heroine) coughed and expelled blood on my bare hands (apparently he had some lung disease). Do I now have hepatitis? I know that it's very common among drug addicts, and that it's transmitted through blood contact. I checked my hands and I didn't have any wounds or scratches, but I heard the virus can infect you even if you don't have any wound, is that right?

A. The chances of you getting hep c are very slim to none but my ? to you is why were you not wearing gloves to serve food ?

Q. Is Hepatitis C contagious? My Girlfriend is a carrier for Hepatitis C. She got infected from a blood transfusion as a kid. Can I catch it from her?

A. yes,through oral and sexual intercourse,dont have oral sex and wear a comdom.

Q. How Do You Become Infected With Hepatitis C? Can I get hepatitis C from touching someone with hepatitis?

A. The only way of being infected with hepatitis C virus is by blood to blood connection, for example by an infected needle, blood transfusion, mother to baby transfer during labour or sexual transmission.

More discussions about Hepatitis
This content is provided by iMedix and is subject to iMedix Terms. The Questions and Answers are not endorsed or recommended and are made available by patients, not doctors.
References in periodicals archive ?
In our study, hepatitis C PCR results were available for in 39 out of 49 patients due to loss of follow up.
Even fewer know that more than three-quarters of these deaths result not from acute hepatitis infection, but from liver cancers and cirrhosis caused by chronic infection with hepatitis B or hepatitis C.
In response to this global public health problem, in 2010, the World Health Assembly (WHA) adopted resolution WHA63.18 on viral hepatitis, urging Member States to recognize and address the issue of viral hepatitis through improved prevention and control efforts.
Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV).
Hepatitis B, C and D infection typically occurs after contact with infected bodily fluids.
By investing in diagnostic tests and medicines for treating hepatitis B and C now, countries can save lives and reduce costs related to long-term care of cirrhosis and liver cancer that result from untreated hepatitis.
While stressing on the need of blood screening he said people if once screened and found positive for Hepatitis C, an individual has a 80 to 90 per cent chance of being cured, however patients for Hepatitis B and C must be screened and treatment provided to prevent the spread of the infection.
A total of US $58.7 billion is needed to eliminate viral hepatitis as a public health threat in these 67 countries by 2030.
Speaking on the occasion, Qureshi said that programmes to raise awareness about hepatitis are being conducted across the world, as this disease has made a global impact.
Hepatitis is a viral infection that attacks the liver and can cause both acute and chronic diseases, commonly transmitted from mother to child during birth, as well as through contact with blood or other body fluids.
Globally, we are aiming to reduce new viral hepatitis infections by 90 percent and deaths from chronic hepatitis by 65 percent by 2030, from the baseline of 2015.